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Abstract  
A soil microorganism was discovered to be active against food spoilage, foodborne pathogen 
and antibiotic resistant strains, especially Gram-positive bacteria. The producer strain was 
designated OSY-I1 and identified as Brevibacillus laterosporus based on morphological, 
biochemical and genetic analyses results. The antimicrobial agent produced from OSY-I1, 
after extraction with isopropanol and resuspended in 50% acetonitrile, was purified using 
high performance liquid chromatography (HPLC). Fractions from HPLC were collected and 
tested for their antimicrobial activity. Fractions with highest purity and strongest 
antimicrobial activity were subsequently analyzed by mass spectrometry (MS) and nuclear 
magnetic resonance (NMR). As a summary of both the MS and NMR results, the structure of 
a novel linear lipopeptide, designated brevibacillin, was elucidated. Brevibacillin contains 13 
amino acid residues with a C6-fatty acid chain (FA), 2-hydroxy-3-methylpentanoic acid, 
attached at the N-terminal. Brevibacillin has a molecular weight of 1583.0794 with three 
modified amino acid residues: α,ß-didehydrobutyric acid, ornithine, and valinol. Brevibacillin 
remains all antimicrobial activity after treated at 80°C for 60 min and retained at least 50% 
activity after incubated at pH 3.0 and pH 9.0. Brevibacillin also showed strong antimicrobial 
activity aginst Alicyclobacillus spp., Listeria monocytogenes and methicillin-resistant 
Staphylococcus aureus indicating the potential ability of applying breviacillin to food 
industry and clinical field. 
Introduction 
Any change of a food product that renders it unacceptable, from a sensory point of view, 
is considered a food spoilage event. Food spoilage may be described as any physical damage, 
chemical change (discoloration, oxidization), or microbial deterioration of product quality. 
Microbial spoilage by bacteria/fungi is one of the most common food spoilage (Gram et al., 
2002). For instance, according to Natural Resources Defense Council, in United Kingdom, 
around 2/3 of the household food waste is due to food spoilage, especially microbial spoilage 
(2). 
Compared to food spoilage, a much more severe consequence of microbial 
contamination is foodborne illness. It is, by definition, any diseases caused by consumption 
of a food product. In many cases, foodborne illness is caused by the consumption of 
pathogenic bacteria or their toxins. According to Centers of Disease Control (CDC), 
Salmonella spp. and Clostridium perfringens cause 11% and 10% of foodborne illness cases 
in the United States, respectively; and Salmonella spp. caused 28% of foodborne illness 
resulting in death in 2011 (Scallan et al., 2011).  
It is obvious that antimicrobial agents are needed to combat against spoilage and 
foodborne illness pathogens. However, with the emerging occurrence of antibiotic-resistant 
microorganisms, antimicrobial agents are also urgently needed in the clinical field. In the year 
of 2013, for the first time, CDC classified drug-resistant bacteria into three categories: urgent 
threats, such as Clostridium difficile and carbapenem-resistant Enterobacteriaceae; serious 
threats including vancomycin-resistant Enterococcus (VRE) and methicillin-resistant 
Staphylococcus aureus (MRSA); and concerning threats, for instance, vancomycin-resistant 
Staphylococcus aureus (CDC, 2013). These antibiotic-resistant bacteria, according to CDC, 
has affected more than two million people every year and caused death of 23,000 people as a 
direct result, not including people died from the other situations that were exacerbated by 
these antibiotic-resistant bacteria (CDC, 2013). 
It is very clear that the discovery and application of new antimicrobial agent are of 
paramount importance. Despite the fact that novel antimicrobial agent may be rare to find, 
new antimicrobial agents can be discovered from potential producing microorganisms after 
screening and isolation processes (He et al., 2007; Guo et al., 2012). In this study, we report 
that the discovery of a linear lipopeptide isolated from a soil microorganism, which are very 
active against selected indicators (MIC < 4 μg/ml, including food spoilage, foodborne illness 
and antibiotic resistant strains).  
Materials and Methods 
Strain screening. Fermented food samples were collected from local grocery stores. 
Environmental samples were collected from the campus of The Ohio State University, 
Columbus, Ohio. Briefly, environmental or food subsamples (10 g each) were homogenized 
in 0.1% peptone water using a stomacher for 2 min. Serial dilutions were made from the 
homogenate and aliquot (100 μl) from each dilutions were spread-plated onto trypticase soy 
agar (TSA; BD Diagnostic Systems, Sparks, MD). After incubation at 37°C for 48 hours, 
around 1,500 colonies were tested for their capabilities of producing antimicrobial agent. 
Generally speaking, portions of the colonies were picked by sterile toothpicks onto new TSA 
plates for growing. After incubation at 37°C for 48 hours, soft TSA agar (0.75%) 
pre-inoculated with overnight Listeria innocua ATCC 33090 were directly overlaid on top of 
the testing strains. The overlaid plates were further incubated at 37°C for 16 hours and were 
inspected for clear zones of inhibition against L. innocua. One isolate (designated as OSY-I1) 
demonstrates a clear zone (diameter greater than 3.0 cm) of inhibition against L. innocua. 
Based on its strong antimicrobial activity, OSY-I1 was selected for further analysis 
Cultures and media. TSA was used to propagate the new isolate, OSY-I1. For glycerol stock 
preparation, an overnight culture of OSY-I1 in trypticase soy broth (TSB) was mixed with 80% 
sterile glycerol in a 1:1 ratio and stored at -80 °C. Other strains used for antimicrobial 
spectrum assay are shown in Table 1.   
Strain identification. The characteristic cellular morphology of OSY-I1 was examined by 
Gram staining, and spores were stained with malachite green. The hemolytic property of 
bacterial strain was tested using tryptic soy agar with sheep blood (TSA-SB). The 
biochemical characteristics of OSY-I1 were examined using a commercial kit (API 50 CH test 
strips; bioMérieux, Inc., Durham, NC), following kit manufacture protocols. For genetic 
analysis, 16S rRNA gene sequencing technique was applied (Drancourt et al., 2000). 
Basically, a commercial kit (DNeasy blood and tissue kit; Qiagen, Valencia, CA) was used to 
extract the genomic DNA of OSY-I1. Then, universal primers (16S Forward Primer: 
5’-CCGAATTCGTCGACAACAGAGTTTGATCCTGGCTCAG-3’ and 16S Reverse Primer: 
5’-CCCGGGATCCAAGCTTAAGGAGGTGATCCAGCC-3’) were used to target 16S rRNA 
gene sequence. Finally, by sequencing the PCR product of 16S rRNA and comparing to 
database (Ribosomal Database Project-II; http://rdp.cme.msu.edu), the species of the 
producer strain can be identified. 
Extraction and purification of antimicrobial agents from OSY-I1. Overnight liquid culture 
of OSY-I1 in TSB was spread-plated on TSA plates. After incubation at 37°C for 72 hours, 
bacterial cells were scraped into 50 ml centrifuge tubes by using a microscopic slide. Then, 
isopropanol was added to the centrifuge tube at a ratio of 4:1 (v/w). The centrifuge tubes were 
then agitated and centrifuged. Supernatant were collected and separated by using a high 
performance liquid chromatography equipped with an analytical reverse-phase column (5 μm 
particle size, 250×4.6 mm, Biobasic C18; Thermo Electron Corp., Bellefonte, PA). Fractions 
were collected per minute and combined fractions were dried in beakers. Then, 50% 
acetonitrile was used to resuspend the contents in beakers. The antimicrobial activity of each 
fraction against L. innocua ATCC 33090 was tested. Fractions with antimicrobial activity 
were also re-injected into HPLC to check the purity. Fraction with strongest antimicrobial 
activity and highest purity was subjected to further MS and NMR analysis. 
MS and NMR analysis. Purified antimicrobial agent fraction from the previous step was 
analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS 
analysis, liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and 
NMR analysis. 
MIC determination. HPLC-purified antimicrobial agent, isolated from OSY-I1, was tested 
for its antimicrobial activity against selected bacteria indicators (Table 1) according to 
Clinical and Laboratory Standards Institute (Wikler, 2006). Specifically, stock solutions for 
this purified antimicrobial agent was prepared in DMSO at a concentration of 3,200 μg/ml. 
Two-fold serial dilutions were made as working solutions. The MIC experiment was 
conducted in 96-well microtiter plate including (each well) 178 μl of medium, 20 μl bacterial 
indicators (~2.0×10
4
 CFU/well) and 2 μl of diluted antimicrobial agent. Also, vancomycin 
(Sigma, St. Louis, MO) and nisin (Aplin and Barrett Ltd. Trowbridge, UK) were prepared the 
same as we did for the purified antimicrobial agent. The MIC results were examined after 
incubation at 35°C for 20 hours, and the experiments were done in triplicate. 
Results 
Isolation and identification of OSY-I1. In total, 2,500 isolates were isolated from food or 
environmental samples. Among them, OSY-I1 demonstrated strong (inhibition zone diameter > 
3.0 cm) antimicrobial activity. Based on the biochemical test results compared to online 
database, it showed 99.9% similarity between OSY-I1 and Brevibacillus laterosporus. In 
addition, genetic sequence of 16S rRNA gene (1450 bp) also indicated that isolate OSY-I1 
shares high identity (97.7%) with B. laterosporus. As a summary, OSY-I1 was identified as 
Brevibacillus laterosporus based on both biochemical and genetic approaches.   
Extraction and purification of the antimicrobial agent isolated from OSY-I1. As shown 
in Fig. 1A, the antimicrobial agent was eluted at the retention time of 16.4 min. This active 
fraction was re-injected into HPLC, and a single isolated peak was observed (Fig. 1B), 
suggesting that the compound was purified to homogeneity, and this pure agent was 
designated as brevibacillin. 
MIC determination of brevibacillin. Purified brevibacillin by using HPLC was used for 
MIC determination. Selected bacterial indicators are shown in Table 1. Based on Table 1, 
brevibacillin demonstrated more potency in terms of antimicrobial activity and it also showed 
similar inhibition ability with vancomycin.  
MS and NMR analysis. The MS results (Fig.3) showed that the compound has a molecular 
weight of 1583.0794 and it is consisted with 11 amino acids, without the structural 
elucidation at both N- and C-terminal. The NMR results indicated 13 amino acids residues 
and confirmed MS results on many aspects. Both technique, taken together, discovered a 
novel structure of brevibacillin which is shown in Fig. 2. 
In conclusion, the chemical structure of brevibacillin was elucidated as a lipopeptide. It 
showed strong antimicrobial activity against food spoilage, foodborne illness and antibiotic 
resistant strains indicating its potency to apply as a food additive and an antibiotic agent.  
Table 1. MIC (μg/ml) of brevibacillin, vancomycin, and nisin against selected bacteria 
including food spoilage, foodborne illness and antibiotic-resistant indicators  




1.0 <0.5 <0.5 
A. acidoterrestris ATCC 49025 0.5-1.0 <0.5 <0.5 
Bacillus cereus ATCC 11778 2.0-4.0 2.0-4.0 8.0 
B. cereus ATCC 14579 1.0 1.0 2.0 
Clostridium difficile A515 4.0-8.0 2.0 4.0-8.0 
C. difficile CL148 4.0-8.0 2.0 4.0-8.0 
Enterococcus faecalis ATCC 29212 2.0 2.0 >16.0 
E. faecalis ATCC 51299, vancomycin 
resistant
 
4.0-8.0 >16.0 >16.0 
Lactobacillus plantarum ATCC 8014 1.0 >16.0 <0.5 
Lactococcus lactis ATCC 11454 2.0 <0.5 >16.0 
Listeria innocua ATCC 33090 1.0-2.0 1.0 2.0-4.0 
L. monocytogenes OSY-8578 1.0-2.0 1.0 <0.5 
L. monocytogenes Scott A
 
1.0 1.0 4.0 
Staphylococcus aureus ATCC 6538 1.0-2.0 1.0 1.0 
S. aureus, methicillin resistant (MRSA)
 
1.0 1.0-2.0 2.0-4.0 
Gram-negatives 
Escherichia coli K-12 >32 >16 >16 
E. coli O157:H7 EDL 933 32 >16 >16 
Pseudomonas aeruginosa ATCC 27853 >32 >16 >16 
Salmonella Typhimurium DT 109 >32 >16 >16 
 
 
Figure 1. [A] HPLC chromatogram of brevibacillin containing crude extract; [B] Purified 
fraction re-injected into HPLC and showed a single, isolated peak. 
 
 
Figure 2. Chemical structure of brevibacillin, which includes 13 amino acid residues with a 
lipid chain attached at N-terminal. 
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Figure 3. Molecular weight of brevibacillin, as analyzed by MALDI-TOF. 
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